The disruption of the IGF2 promoter regulation is a common feature of human HCCs suggested that the frequent loss of biallelic IGF2 expression as a result of the loss of P1 activity may potentially be used as a diagnostic or monitoring marker for human HCC [125,126]. The gene discussed is IGF2; the disease is hepatocellular carcinoma.